BMP-2 Peptide Immobilized on Demineralized Bone Matrix
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current bone healing methods using synthetic scaffolds or Demineralized Bone Matrix (DBM) with recombinant BMP-2 growth factor, such as INFUSE, face challenges like uncontrolled bone growth in surrounding tissues, inflammation, and side effects due to the growth factor's migration from the scaffold, leading to safety concerns and reduced efficacy.
Innovation Solution
A synthetic peptide mimicking the active sequence of BMP-2 is bound to a collagen-based scaffold, specifically Demineralized Bone Matrix (DBM), to immobilize the growth factor, preventing migration and enhancing safety and efficacy by maintaining higher concentrations locally.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If high concentrations of recombinant BMP-2 are applied to accelerate bone healing, then bone healing rate is dramatically increased, but the growth factor migrates away from the scaffold causing unwanted side effects such as bone growing in surrounding tissues, inflammation, seroma, swelling and radiculopathy
Solution Approach 1:
The BMP-2 growth factor is pre-coated onto the collagen sponge scaffold before implantation, ensuring it is positioned exactly where needed. This preliminary action prevents migration to surrounding tissues while maintaining high local concentration for accelerated bone healing.
Solution Approach 2:
The collagen sponge acts as an intermediary carrier that holds the BMP-2 growth factor in place. The scaffold mediates between the growth factor and the bone defect site, delivering controlled amounts locally without allowing migration to surrounding tissues.
2Ease of operation
If BMP-2 is not bound to the scaffold, then it is free to migrate away after implantation, but this migration causes bone to grow in surrounding tissues leading to injury or death
Solution Approach 1:
The BMP-2 growth factor is merged with the collagen sponge scaffold through coating, creating a unified implantable unit. This combination ensures the growth factor remains固定在 the scaffold and cannot migrate independently, eliminating safety risks while maintaining ease of implantation.
3Reliability
If synthetic scaffold or Demineralized Bone Matrix is used alone, then bone cells can adhere and grow, but bone healing is quite slow
Solution Approach 1:
The invention creates a composite material by coating recombinant BMP-2 growth factor onto a collagen sponge scaffold. This composite combines the safety and biocompatibility of the synthetic/collagen scaffold with the osteoinductive power of BMP-2, achieving both safe and rapid bone healing.
Solution Approach 2:
The invention changes the concentration parameter of BMP-2 by using high concentrations coated on the scaffold, which dramatically accelerates bone healing compared to natural BMP-2 levels in demineralized bone alone, while the scaffold controls delivery to maintain safety.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The immobilized peptide significantly accelerates bone healing with reduced side effects, achieving faster and more effective bone regeneration without the risks associated with recombinant BMP-2 migration, while maintaining safety and ease of use.
Implementation Method 1
a chemical group attached to the peptide that will bond the peptide to the collagen carrier or the collagen in the DBM scaffold
Data Source
AI summary
Described herein are compositions comprising a BMP-2 derived peptide conjugated to albumin for use in bone grafts. The composition may further include bone matrix, such as demineralized bone matrix (DBM).